Iron fumarate

When ATH:
B03AA02

Pharmacological action.
Hematopoietic, erythropoietic, antianemic.

Application.

Iron deficiency anemia: posthemorrhagic (menorragii, chronic blood loss in the gastrointestinal tract and others.); increased need for iron (pregnancy, lactation, a period of intense growth and puberty, particularly for girls) - Treatment and Prevention; insufficient intake of iron from food or violation of its absorption (chronic diarrhea, glistnaya invasion); Iron deficiency anemia in elderly and senile (as a trial treatment).

Contraindications.

Hemolytic (hereditary and acquired) and etc. anemia, not associated with iron deficiency, gemoxromatoz, gastric ulcer and duodenal ulcer in the acute phase, inflammatory bowel disease (Crohn's disease, nespetsificheskiy yazvennыy colitis).

Side effects.

Anorexia, metallic taste in mouth, nausea, vomiting, constipation, diarrhea.

Cooperation.

Violates (mutually) the absorption of tetracycline antibiotics. Almagel and magnesium salts impair absorption from the intestine.

Overdose.

Symptoms: nausea, epigastric pain, vomiting blood, diarrhea, dizziness, weakness, confusion, acrocyanosis, low blood pressure, low pulse.

Treatment: stimulation of vomiting, gastric lavage (at an early stage), appointment of milk with egg white; for specific (appointment of oral and parenteral deferoxamine) and symptomatic therapy.

Dosing and Administration.

Inside, fasting, for 30 minutes before breakfast, adults and children over 12 years - 1 caps. a day or 10 3.4 ml of the suspension twice daily for 6-12 weeks. the dose may be increased with little effect - by 1 caps. 2 once a day. Reception continues after normalization of the blood picture. The duration of therapy saturating at least 1-1,5 months. Children under 2 years 5 ml suspension 1 once a day, 2-6 years - 2 once a day, senior 6 years - 3-4 times a day. The suspension was taken in between meals, high water (but not tea).

Precautions.

Requires regular monitoring of hematological parameters: a sign of the effectiveness of treatment is to increase the number of reticulocytes in the 7-10 day from the beginning and the normalization of hemoglobin levels 3-4 (sometimes 6-8) of the week. In case of bad tolerance shown to decrease the dose, taking the drug during meals, as well as a short-term break in treatment.

Cooperation